GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1GILD • US3755581036

128.32 EUR
+7.58 (+6.28%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

6

1GILD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 81 industry peers in the Biotechnology industry. 1GILD scores excellent on profitability, but there are some minor concerns on its financial health. 1GILD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make 1GILD suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year 1GILD was profitable.
  • In the past year 1GILD had a positive cash flow from operations.
  • In the past 5 years 1GILD has always been profitable.
  • 1GILD had a positive operating cash flow in each of the past 5 years.
1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCF1GILD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.86%, 1GILD belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • The Return On Equity of 1GILD (37.80%) is better than 95.29% of its industry peers.
  • 1GILD has a better Return On Invested Capital (18.54%) than 96.47% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1GILD is above the industry average of 12.03%.
  • The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1GILD.MI Yearly ROA, ROE, ROIC1GILD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 27.88%, 1GILD belongs to the best of the industry, outperforming 85.88% of the companies in the same industry.
  • 1GILD's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 38.96%, 1GILD belongs to the best of the industry, outperforming 95.29% of the companies in the same industry.
  • 1GILD's Operating Margin has improved in the last couple of years.
  • 1GILD has a Gross Margin of 78.72%. This is in the better half of the industry: 1GILD outperforms 70.59% of its industry peers.
  • 1GILD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
1GILD.MI Yearly Profit, Operating, Gross Margins1GILD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1GILD is creating value.
  • The number of shares outstanding for 1GILD remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for 1GILD has been reduced compared to 5 years ago.
  • 1GILD has a worse debt/assets ratio than last year.
1GILD.MI Yearly Shares Outstanding1GILD.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1GILD.MI Yearly Total Debt VS Total Assets1GILD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • 1GILD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC2.23
WACC8.3%
1GILD.MI Yearly LT Debt VS Equity VS FCF1GILD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that 1GILD should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.53, 1GILD is doing worse than 60.00% of the companies in the same industry.
  • 1GILD has a Quick Ratio of 1.17. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
  • 1GILD has a worse Quick ratio (1.17) than 61.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
1GILD.MI Yearly Current Assets VS Current Liabilites1GILD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

  • 1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -7.01% on average over the past years.
  • Looking at the last year, 1GILD shows a small growth in Revenue. The Revenue has grown by 2.78% in the last year.
  • Measured over the past years, 1GILD shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

  • 1GILD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.03% yearly.
  • 1GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1GILD.MI Yearly Revenue VS Estimates1GILD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
1GILD.MI Yearly EPS VS Estimates1GILD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.49, the valuation of 1GILD can be described as rather expensive.
  • 1GILD's Price/Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 87.06% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.93. 1GILD is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 16.97, the valuation of 1GILD can be described as correct.
  • Based on the Price/Forward Earnings ratio, 1GILD is valued cheaper than 84.71% of the companies in the same industry.
  • 1GILD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 18.49
Fwd PE 16.97
1GILD.MI Price Earnings VS Forward Price Earnings1GILD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 83.53% of the companies in the same industry.
  • 1GILD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1GILD is cheaper than 88.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.72
EV/EBITDA 12.65
1GILD.MI Per share data1GILD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • 1GILD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1GILD's earnings are expected to grow with 27.78% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y39.1%
EPS Next 3Y27.78%

6

5. Dividend

5.1 Amount

  • 1GILD has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.64, 1GILD pays a better dividend. On top of this 1GILD pays more dividend than 91.76% of the companies listed in the same industry.
  • 1GILD's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of 1GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
1GILD.MI Yearly Income VS Free CF VS Dividend1GILD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1GILD.MI Dividend Payout.1GILD.MI Dividend Payout, showing the Payout Ratio.1GILD.MI Dividend Payout.PayoutRetained Earnings

GILEAD SCIENCES INC

BIT:1GILD (2/6/2026, 7:00:00 PM)

128.32

+7.58 (+6.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap159.20B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target118.53 (-7.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.67
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)7.54%
PT rev (3m)5.6%
EPS NQ rev (1m)-2.7%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 18.49
Fwd PE 16.97
P/S 6.46
P/FCF 19.72
P/OCF 19.42
P/B 8.75
P/tB N/A
EV/EBITDA 12.65
EPS(TTM)6.94
EY5.41%
EPS(NY)7.56
Fwd EY5.89%
FCF(TTM)6.51
FCFY5.07%
OCF(TTM)6.61
OCFY5.15%
SpS19.88
BVpS14.66
TBVpS-3.3
PEG (NY)0.23
PEG (5Y)N/A
Graham Number47.85
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC8.3%
ROIC/WACC2.23
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.27%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / 1GILD.MI FAQ

What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.


What is the valuation status for 1GILD stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.


Can you provide the profitability details for GILEAD SCIENCES INC?

GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?

The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 18.49 and the Price/Book (PB) ratio is 8.75.


What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?

The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.